Aclaris Therapeutics, Inc. (ACRS) › Total AssetsAclaris Therapeutics, Inc. (ACRS) — Total AssetsAnnual figures by fiscal year, from SEC filings.2014: $17.38M2015: $94.08M2016: $176.09M2017: $243.51M2018: $275.57M2019: $98.30M2020: $70.78M2021: $251.21M2022: $254.60M2023: $197.41M2024: $220.33M2025: $160.46M$160.46M2014Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$160.46M-27.2%2024$220.33M+11.6%2023$197.41M-22.5%2022$254.60M+1.3%2021$251.21M+254.9%2020$70.78M-28.0%2019$98.30M-64.3%2018$275.57M+13.2%2017$243.51M+38.3%2016$176.09M+87.2%2015$94.08M+441.4%2014$17.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share